The blood levels of several biomarkers for AD and co-morbid diseases, including proinflammatory markers, neurodegenerative markers and markers from the pathways affected in AD, such as amyloid precursor protein (APP) processing, neurofibrillary tangle (NFT) formation and synapse formation, are described. This evidence concerns the gene APP and Alzheimer disease.